Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia
Technology Appraisal Guidance No. 193 Source: National Institute for Health and...
Jump to:
Click on a title in the list below to view the relevant table.
Technology Appraisal Guidance No. 192 Source: National Institute for Health and...
Technology Appraisal Guidance No. 193 Source: National Institute for Health and...
Technology Appraisal Guidance No. 191 Source: National Institute for Health and...
Technology Appraisal Guidance No. 190 Source: National Institute for Health and...
Technology Appraisal Guidance No. 188 Source: National Institute for Health and...
Educational resource for the learning and teaching of the
GP curriculum
Cumulative list of products discontinued from the UK market
in 2010
Healthcare Republic resource centre for diagnosing and managing psoriasis
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.